Quinn is originally from northern Illinois and has a BA in Public Health from American University and a MPH in Health Law, Bioethics, and Human Rights from Boston University. She is a policy analyst at the Office of Information and Regulatory Affairs (OIRA) in the Office of Management and Budget. Previously, she was the Associate Research Director for Health Policy at National Journal’s Network Science Initiative.

Kelly Singel, PhD, (she/her) is a Health Science Policy Analyst at the National Institutes of Health (NIH)*. She works to capture, communicate, and enhance the value of NIH research through stewardship activities including strategic planning, evaluation, and reporting. Her portfolio focuses on implementing mandates specific to the NIH in the 21st Century Cures Act of 2016 and the Foundations for Evidence-Based Policymaking Act of 2018. In this role, Dr. Singel prioritizes communicating the impact of NIH research on science, health, and society to NIH’s stakeholders, the American people.

Dr. Singel received her Bachelor’s degree in Neuroscience and Anthropology, with a minor in Chemistry, from the University of Pittsburgh, and her PhD in Microbiology and Immunology, with a focus in Tumor Immunology, from the University at Buffalo and Roswell Park Comprehensive Cancer Center. Her doctoral and post-doctoral work focused on identifying strategies to enhance the anti-tumor immune response in patients with metastatic ovarian cancer. In 2018, Dr. Singel was a Christine Mirzayan Science & Technology Policy Graduate Fellow at the National Academies of Sciences, Engineering, and Medicine. There she gained experience translating her knowledge of biomedical research into health care policy recommendations. From 2019-2020, Dr. Singel was a AAAS Science & Technology Policy Fellow at the NIH.

Dr. Singel is proud to serve as an ambassador for the AAAS Science & Technology Policy Fellowship and the Christine Mirzayan Science & Technology Policy Graduate Fellowship by recruiting and empowering the next generation of scientists turned policy wonks. Aside from her professional interests, she enjoys traveling to wherever she can be on the water, hike a beautiful trail, or taste local wines.

*Dr. Singel serves SHPYP in her personal capacity.

Olivia Umoren is the Director of Public Policy and Advocacy at USAging in Washington, DC. In this role, she directs the association’s legislative and federal advocacy efforts to advance policies that address the needs of older adults in America. She is also the Founder and CEO of LIV Consulting & Career Services, a business that supports public health and health policy students and professionals in navigating their careers. 

Brittany Argote is a Senior Health Policy Associate at Thorn Run Partners, where she tracks and provides analysis for federal health policy through both the legislative and regulatory processes, leads health care policy and research projects for clients, and orchestrates advocacy campaigns on a variety of health care issues for some of Washington’s most influential stakeholders.

Brittany’s work has spanned local, state, and federal governments, giving her a unique view of the policy lifecycle. Prior to joining Thorn Run, Brittany served as a legislative analyst for the Florida Senate, where she routinely analyzed complex policy issues and authored detailed legislative analyses, developed targeted legislative proposals, and drafted legislation and amendments for members of the Florida Legislature. Previously, Brittany served as a legislative committee assistant for the Florida Senate, where she conducted writing and research projects to help better inform policy decisions. As an undergraduate, Brittany served as a legal intern for the U.S. Department of Justice where she monitored the policy landscape for issues pertaining to civil and disability rights.

Brittany is a two-time graduate of Florida State University, where she received a Master of Science in Public Health Policy and a Bachelor of Arts in English.

Kei Helm is a Presidential Management Fellow (PMF) serving as a Health Insurance Specialist at the Center for Consumer Information and Insurance Oversight (CCIIO) in the Centers for Medicare and Medicaid Services (CMS). In CCIIO’s Oversight Group*, he supports policy and regulation development to ensure that individuals covered by private health insurance receive the coverage to which they are entitled to under the law. In this capacity, he has helped develop guidance on COVID-19 testing and vaccine insurance coverage based on Families First Coronavirus Response Act and CARES Act requirements; provided clarity to providers and consumers regarding the requirements of, and protections under, the No Surprises Act; and prepared rulemaking and guidance regarding the Affordable Care Act’s requirements on contraceptive care coverage.  

Previously, Kei worked at The Lewin Group where he supported the Center for Medicare & Medicaid Innovation in developing and implementing Medicare alternative payment models. He also assisted with the implementation of the Quality Payment Program through the Small, Underserved and Rural Support initiative.

Kei holds a B.A. in Biology from Kenyon College and a Master of Public Policy from Georgetown University’s McCourt School of Public Policy.

* Kei serves SHPYP in his personal capacity.

In her professional capacity, Lauren Olcott is a Health Policy Associate at SCAN Health Plan where she supports the public and government affairs interests of the plan and its beneficiaries. In this role, Lauren conducts regulatory and legislative research on the Medicare Advantage program and tracks and analyzes legislation at federal and state levels. 

Throughout her educational career, Lauren has demonstrated an immense interest in health coverage and access policy. Prior to joining SCAN Health Plan, Lauren served in the Office of Financial Management at CMS through the Pathways Program and worked on Medicaid reimbursement policy at a D.C. government affairs firm. 

Lauren is originally from San Diego, CA and holds a BA in Global Health and Communications from UCLA. She is currently pursuing her MPP with a focus in health policy at George Washington University where she has conducted research on differences between state Medicaid prescription drug programs and the intricacies of Medicare Advantage. 

Abigail Smith is a health policy coordinator at the National Governors Association (NGA). On the health team, Abigail supports Governors in identifying ways to improve healthcare delivery, lower costs to states, and promote health equity.

Abigail previously worked as a Registered Nurse at Children’s National on the Surgical and Trauma floor and at Vanderbilt University Medical Center on the Transplant floor. After working through the pandemic, Abigail hoped to find a way to make more of an impact on her patients. She is excited to pursue a career in health policy and obtain her Master in Public Health from George Washington University.  

In her spare time, Abigail serves as a Court Appointed Special Advocate for a child in the DC foster care system, research assistant on the moral injury project at the Mullen Institute for Health Workforce Equity, and directs a women’s walking group called City Girls Who Walk DC. Abigail hopes to combine her passion for people and community into shaping policy.

Emma Hammer is a Health Policy Associate at Applied Policy, a health policy consulting firm. She performs health policy research and analysis for pharmaceutical, durable medical equipment, and healthcare services companies.

While finishing her degree, Emma was a student trainee at the Centers for Medicare and Medicaid Services. She worked on projects related to Medicare Advantage and the Value-Based Insurance Design Model for the Center for Medicare and Medicaid Innovation (CMMI).

Emma graduated with a Bachelor of Arts in Public Policy and a minor in general business, summa cum laude, from the University of Maryland, College Park.

Emely Sanchez, JD, MPH, is a public health law and policy professional. Born and raised in Miami, FL, she holds undergraduate degrees in political science and criminal justice from Florida International University. She pursued her Masters in Public Health and Juris Doctorate at the University of Miami. 

Throughout her educational career, she has been interested in public service. She interned at multiple offices within DHHS including CSTLTS and CGH at CDC, HHS OIG, and at the U.S. Senate HELP Committee.  

She has enjoyed organizational involvement and volunteering. Throughout her time at Miami Law she reestablished Miami Law’s Health Law Association and was an active leader in the American Bar Association’s Health Law Section. She currently serves as the Hispanic National Bar Association’s Health & Life Sciences Section’s VP for Policy & Publications. She has also recently been selected as an ASLME Expanding perspectives fellow for 2022-2023. 

She enjoys growing her expertise through producing publications and community engagement. She is currently a legal fellow at the Network for Public Health Law. 

Daniel Machado is an attorney in the Washington, D.C. office of Latham & Watkins. Daniel handles healthcare regulatory matters involving healthcare providers as well as pharmaceutical, biotechnology, medical device, digital health, and clinical laboratory companies. In particular, he advises clients on complex regulatory, compliance, business and policy considerations involving the Centers for Medicare and Medicaid Services. In addition, Daniel advises private equity firms, investment banks, commercial lenders, and healthcare and life science companies on regulatory issues related to mergers and acquisitions, IPOs, and financings in the United States.

Daniel earned his JD from Northwestern University School of Law, graduating with honors. He was a staff editor of the Northwestern Journal of Technology and Intellectual Property, a member of OUTLaw, and a member of the Latino Law Student Association. Prior to law school, Daniel completed an MPH from the Yale School of Public Health, focusing on health policy and management.

Samantha (Sam) Burkhart serves as Special Assistant to Liz Fowler at the Center for Medicare and Medicaid Innovation (CMMI) and a 2022-2023 David A. Winston Health Policy Fellow. Prior to her role at CMMI, Sam attended Boston University’s School of Public Health and graduated in May 2022 with a Master of Public Health in Health Policy and Law. She most recently worked in the Massachusetts Statehouse for Representative Christine Barber where she worked on prescription drug pricing policy. Prior to her public service role, Sam was the Government Affairs Intern for the Association of Maternal and Child Health Programs. Sam’s interests lie in health care financing and delivery system reform.

Caitlin Davis is a physician and economist, passionate about expanding access to health care and improving patient experiences through payment model innovation. With clinical training in mental health and primary care, she excels in translating patient perspectives for systemic improvement. She is a mixed-methods researcher, with experience evaluating components of the CMS Medicare ACO model and the Medicare Quality Bonus Payment structure, and has published on topics including the impact of primary care continuity on patient outcomes, healthcare workforce implications of service-based student loan forgiveness, and expansions in access to care as a result of novel models of physician training.

Caitlin holds a BA in Economics from The College of William & Mary (Williamsburg, VA), a MSc in Economics from The University of Warwick (Coventry, UK), and a MD from The George Washington University School of Medicine & Health Sciences (Washington, DC).

 Cameron Kay is a Health Care Analyst at the National Committee for Quality Assurance in Washington, DC. In this role she supports multiple externally and internally funded projects and programs focused on health care policy and performance measurement.

Previously she worked on both global and U.S. health care projects to measure the impacts of SDOH factors on care seeking and clinical outcomes for behavioral and maternal health.  

Cameron earned her B.A. from the University of Chicago, graduating with honors in comparative human development and political science. 

Tyler Adamson holds an MPH in Health Policy and Epidemiology from the Johns Hopkins School of Public Health, and a BS/BA in Molecular Biology and Anthropology from the University of Washington. Tyler is currently the Director of Epidemiology for the Maryland Department of Health’s Center for Cancer Control and Prevention, where he provides guidance and direction on all epidemiology and program evaluation efforts. He previously worked as a Desk Officer at the Department of Defense and as a Health Policy Staffer in the office of Congressman Trone. Tyler is passionate about human rights, equity in health, and ensuring that every individual has access to the resources they need to live a healthy and happy life.

Joy Kraybill’s career has spanned both health program operations and health policy research. Whether through operations or research, her career goal is to contribute to the improvement of publicly-supported health programs.
Since 2012, Joy has worked directly on the implementation of the Federally-Facilitated Marketplaces (FFM) at the Centers for Medicare and Medicaid Services’ (CMS) Center for Consumer Information and Insurance Oversight (CCIIO). At CCIIO, Joy initially built the team that oversees health plan issuers in the FFM, and she designed and implemented the program which trains and registers health insurance agents to sell plans on the FFM. She now serves as the Deputy Group Director for the CCIIO component that provides Marketplace consumers with eligibility determinations and enrolls them in FFM coverage. This group is responsible for an annual operating budget of over $300 million dollars, and the group’s work directly touches millions of consumers each year.

Prior to joining CCIIO, Joy spent 1.5 years supporting CMS’ Medicaid Integrity Group (MIG).

From 2009-2010, Joy led the Program Integrity Division for the DC Medicaid program. At DC Medicaid, she supervised all on going fraud investigations, established performance goals for the division, and ensured those goals were met.

Previously, Joy spent 9 years at the U.S. Government Accountability Office (GAO), where she led teams in the development of Congressional reports and testimonies that focused on curbing fraud, waste, and abuse in Medicare and Medicaid.

Joy initially launched her career as a Presidential Management Fellow (PMF) in the U.S. Department of Health and Human Services.

Joy earned her Ph.D. in Public Policy at The George Washington University. She also holds a Master of Public Administration from North Carolina State University.

In addition, Joy serves as a peer reviewer for the Journal for Healthcare Quality, and she enjoys mentoring young professionals.

Dr. Lauren Lyles-Stolz currently serves the National Association of Chain Drug Stores (NACDS) as a senior director of reimbursement, innovation, and advocacy. Most recently, she served as health legislative assistant for U.S. Rep. Bradley S. Schneider (D-IL). Previously, she served as Executive Director for the Washington State Pharmacy Quality Assurance Commission. Furthermore, she was the first pharmacist German Chancellor Fellow researching Population Health Management primarily in Germany as a solution to ensure health equity, address rising healthcare cost, and to improve health outcomes. In her recent experiences, she has had the unique opportunity to regulate and support the profession of pharmacy during the COVID-19 pandemic as well as meet and discuss health challenges and successes with international health experts in Singapore, Israel, Scotland, Spain, and Switzerland. She authored her first joint population health publication with Scotland and Germany titled, Population Health Management Approach: Integration of Community-Based Pharmacists into Integrated Care Systems: Reflections from the U.S., Achievements in Scotland and Discussions in Germany.
Since then, Lauren has spoken at diverse institutions to share her research findings, including the 2021 Health Technology Research Summit in Brazil.

Lauren graduated with her Pharm.D. (Doctor of Pharmacy) from The University of Mississippi School of Pharmacy. Following graduation, Lauren completed her post-doctoral fellowship at Eli Lilly and Company in U.S. and International Regulatory Policy and Strategy. The fellowship entailed her combining her patient care experiences throughout her pharmacy curriculum, background from national pharmacy associations (NACDS, NCPA) and FDA, with the pharmaceutical industry to improve patient access to innovative therapies. She also worked part-time as a pharmacist at a mail-order pharmacy making sure the right medications got to the right patients in the criminal justice system. Lauren then served as the Manager of Pharmacy Affairs at the Academy of Managed Care Pharmacy, where she supported the association’s efforts to promote the transition of managed care pharmacy to value-based healthcare. These experiences and relationships both globally and stateside have shaped Dr. Lyles-Stolz’s passion to improve health for all.

Stuart Portman serves as Senior Health Policy Advisor on the U.S. Senate Committee on Finance. In this capacity, he handles all policies related to Medicaid and the Children’s Health Insurance Program, and in the past has led policy development on issues related to the Affordable Care Act’s individual marketplace, health taxes, and health information technology. Previously, he served as the Senior Healthcare Legislative Assistant and Legislative Correspondent for Senator Orrin G. Hatch, where he focused on Medicaid, Food and Drug Administration-related policies, and issues affecting individuals with disabilities. A native of St. Louis, Missouri, Stuart received his Master of Public Health degree specializing in health policy from the Milken Institute School of Public Health at The George Washington University and his Bachelor’s in Biology and Political Science from the University of Denver.